| Market Cap | ₹65Cr |
| ROE | -8.42% |
| P/E Ratio(TTM) | -9.60 |
| EPS(TTM) | -1.49 |
| P/B Ratio | 0.90 |
| Dividend Yield | 0.00% |
| Industry P/E | 29.64 |
| Book Value | 15.92 |
| Debt to Equity | 1.89 |
| Face Value | 10 |
| Parent Organisation | Indrayani Biotech |
| Managing Director | Mr. Kasiraman Sundar |
| BSE Symbol | 526445 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| TTK Healthcare | NA (0.00%) | 24.14 | ||
| Andrew Yule & Co | NA (0.00%) | 249.30 | ||
| Meghna Infracon Infrastructure | NA (0.00%) | 111.31 | ||
| Sobhaygya Mercantile | NA (0.00%) | 35.90 |